Dimmock, N.J.
Nigel Dimmock virologist
Dimmock, Nigel J.
Dimmock, N.J. (Nigel J.)
VIAF ID: 94025544 (Personal)
Permalink: http://viaf.org/viaf/94025544
Preferred Forms
- 200 _ | ‡a Dimmock ‡b N. J.
- 100 1 _ ‡a Dimmock, N J
- 100 1 _ ‡a Dimmock, N. J
- 100 1 _ ‡a Dimmock, N. J.
-
-
-
-
- 100 1 _ ‡a Dimmock, N. J.
-
- 100 1 _ ‡a Dimmock, N. J.
-
-
-
-
-
-
- 100 0 _ ‡a Nigel Dimmock ‡c virologist
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
Control of virus diseases : Forty-fifth Symposium of the Society for General Microbiology, held at the University of Warwick, April 1990 | |
Effect of Antibody to Neuraminidase on the Maturation and Hemagglutinating Activity of an Influenza A 2 Virus | |
The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo | |
IgG-neutralized influenza virus undergoes primary, but not secondary uncoating in vivo | |
Immune responses, virus infections, and disease | |
Increasing the efficiency of virus infectivity assays: small inoculum volumes are as effective as centrifugal enhancement | |
Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. | |
Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing. | |
Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection. | |
Internal proteins of influenza virus: 35S-methionine peptide maps as genetic markers | |
Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization | |
Introduction to modern virology, 2007: | |
Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA. | |
Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions. | |
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir. | |
Mechanisms of neutralization of influenza virus on mouse tracheal epithelial cells by mouse monoclonal polymeric IgA and polyclonal IgM directed against the viral haemagglutinin | |
Mims' pathogenesis of infectious disease | |
The multiplication of influenza virus in enucleated BHK cells fused with chicken erythrocytes | |
n80000501 | |
Neutralization of animal viruses, 1993: | |
Neutralization titres of HIV-1-specific monoclonal antibodies vary according to the batch of primary human peripheral blood lymphocytes, but do not vary coordinately | |
The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope | |
Newly Synthesized Influenza Virus Proteins are Transported from the Nucleus | |
Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion. | |
Phosphorylation of Influenza Virus Nucleoprotein in vivo | |
Polyadenylic acid sequences in rhinovirus RNA species from infected human diploid cells | |
Polymorphism of the NS1 proteins of type A influenza virus | |
Postattachment neutralization of a primary strain of HIV type 1 in peripheral blood mononuclear cells is mediated by CD4-specific antibodies but not by a glycoprotein 120-specific antibody that gives potent standard neutralization. | |
Processing of exogenous poly(A) added to virus-infected cells | |
Production of long-lived neutralizing antibodies to HIV-1 IIIB in mice with a vaccinia recombinant virus-infected cell vaccine expressing gp160. | |
Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions | |
Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus | |
Quantitative relationships between an influenza virus and neutralizing antibody | |
The receptor preference of influenza viruses | |
regulation of lymphocyte traffic | |
Review article initial stages in infection with animal viruses | |
Rhinovirus multistranded RNA: dependence of the replicative form on the presence of actinomycin D | |
Rhinovirus RNA polymerase: products and kinetics of appearance in human diploid cells | |
Selection of neutralizing antibody escape mutants with type A influenza virus HA-specific polyclonal antisera: possible significance for antigenic drift | |
Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function | |
Semliki Forest virus infection of mice: a model for genetic and molecular analysis of viral pathogenicity | |
Subclinical infections in mice resulting from the modulation of a lethal dose of Semliki Forest virus with defective interfering viruses: neurochemical abnormalities in the central nervous system | |
Summary of antibody workshop: The Role of Humoral Immunity in the Treatment and Prevention of Emerging and Extant Infectious Diseases | |
Temporal control of transcription of influenza virus RNA | |
Uirusugaku nyumon. | |
Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA. | |
Valency of antibody binding to virions and its determination by surface plasmon resonance | |
Variation in homotypic and heterotypic interference by defective interfering viruses derived from different strains of Semliki Forest virus and from Sindbis virus | |
Varying temperature-dependence of post-attachment neutralization of human immunodeficiency virus type 1 by monoclonal antibodies to gp 120: identification of a very early fusion-independent event as a neutralization target | |
ウイルス学入門 |